Manage Your Liver
Q:

Why does the current hepatitis B drug treatment have serious deficiencies?

Why does the current hepatitis B drug treatment have serious deficiencies?
A:

The current medication for hepatitis B may be able to stop virus replication, but there are also some major shortcomings, mainly due to the toxicity of the drug itself.1 In addition, the patient is required to use the drug for a long period without stopping. Besides, the medication cannot prevent liver fibrosis and does not contribute to liver health protection.2 So what can chronic hepatitis B patients do to make up for these shortcomings? Is a better or more comprehensive treatment possible?

 

Chronic hepatitis B is a common liver disease where the hepatitis virus continuously replicates in the body, attacking the liver and leading to chronic inflammation. Patients normally have a high level of liver enzymes (ALT & AST). Now, the current main stream treatment is to use medication to control the replication of hepatitis virus, so that the virus count lowers, thereby reducing the attacks and inflammation of the liver. 3

 

It has to be made clear that the only purpose of this medication is to limit and stop viral replication, meaning that it does not and cannot cure the disease. Moreover, the patient is required to take the medication for life, because once it is stopped, the virus will resume its replication. Also, the medication does not promote recovery of liver cells, meaning that the inflammation or damage done remains until the liver is repaired by itself. Most importantly, using the medication does not guarantee that liver function will return to normal as this depends on the liver’s  own recovery ability.

 

Another obvious downside of the drug is that like all other drugs, it contains toxicity. Long-term use will definitely pose adverse effect on human health, especially the liver, since it is the main organ responsible for the decomposition of toxins. 4

 

The disadvantages of using medication to treat chronic hepatitis B are evident; therefore measures to make up for these shortcomings should be incorporated into the treatment program to make it more all-rounded. Patients are recommended to enhance their liver’s self-healing ability and to adopt protective measures to guard liver health. Only by doing these can patients ensure their liver cells are protected from injuries caused by long term medications, not suffer from any side effects of the drugs and prevent liver fibrosis, cirrhosis and other chronic liver diseases

 

Click for more information about enhancing liver’s self-healing ability and protection.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Tags:
hepatitis B treatmenthep B medicationhepatitis B drug treatmentliver protection
Related Questions
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health. Multiple studies have demonstrated that the presence of an elevated ALT level is associated with increased liver-related mortality.   New normal ALT level issued The American College of Gastroenterology (ACG) recently issued a new Practice Guideline that aims to offer a framewor
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
Hit Questions
A:
Cancer is a leading cause of morbidity and mortality in the United States and results in a high economic burden. A recent research published by The JAMA Network has reveal that cancer mortality declined overall in the United States between 1980 and 2014. And the number of deaths for nearly all forms of cancer has decreased significantly, but not for liver cancer, kidney cancer and non-Hodgkin lymphoma (NHL) cancer.   Deaths due to NHL and kidney cancer remained the sa
A:
Recent research by the University of Edinburgh have gained new insight into how common painkiller paracetamol causes liver damage. The research studied the impact of paracetamol on liver cells in human and mouse tissue.   Toxicity liver damage is currently the leading cause of acute liver failure in the Western world. Long term or excessive use of paracetamol can damage the liver by harming vital structural connections between cells. One of the common result of toxici
A:
Fatty liver is on the rise and it is quickly becoming one of the most worrying disease in developed countries, a condition that most Americans have never heard of and now experts say as many as one in three of us may be at risk. Fatty liver disease is a gradual killer which often shows no symptoms until it develops into a much server problem like: cirrhosis - a condition that could lead to liver cancer or death.   Douglas Denham is medical director at Clinical Trials
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health. Multiple studies have demonstrated that the presence of an elevated ALT level is associated with increased liver-related mortality.   New normal ALT level issued The American College of Gastroenterology (ACG) recently issued a new Practice Guideline that aims to offer a framewor
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us